LIPOCINE INC. Restructuring Charges
LIPOCINE INC. (LPCN) reported Restructuring Charges of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2019-03-06
- LIPOCINE INC. restructuring charges for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. restructuring charges for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. restructuring charges for the quarter ending 2017-06-30 was $0.00.
- LIPOCINE INC. restructuring charges for the quarter ending 2017-03-31 was $0.00.
- LIPOCINE INC. restructuring charges for fiscal 2018 was $0.00.
- LIPOCINE INC. restructuring charges for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- LIPOCINE INC. restructuring charges for fiscal 2016 was $728.63K.
- LIPOCINE INC. restructuring charges for fiscal 2015 was $0.00.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-06 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $0.00 derived: sum of 3 quarters · filed 2019-03-06 | $0.00 10-K · filed 2019-03-06 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | $343.40K derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $0.00 10-Q · filed 2017-08-07 | $343.40K derived: sum of 3 quarters · filed 2019-03-06 | $728.63K derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-08 | $343.40K derived: sum of 2 quarters · filed 2019-03-06 | $728.63K derived: sum of 3 quarters · filed 2019-03-06 | |
| 2016-12-31 | $343.40K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $728.63K derived: sum of 2 quarters · filed 2019-03-06 | $728.63K 10-K · filed 2019-03-06 | |
| 2016-09-30 | $385.23K 10-Q · filed 2017-11-08 | $385.23K 10-Q · filed 2017-11-08 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $0.00 derived: sum of 2 quarters · filed 2018-03-12 | $0.00 10-K · filed 2018-03-12 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-08 | $0.00 10-Q · filed 2016-11-08 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |